Coleman, Hannah N.
Greenfield, William W.
Stratton, Shawna L.
Vaughn, Rita
Kieber, Alexander
Moerman-Herzog, Andrea M.
Spencer, Horace J.
Hitt, Wilbur. C.
Quick, Charles Matthew
Hutchins, Laura F.
Mackintosh, Samuel G.
Edmondson, Ricky D.
Erickson, Stephen W.
Nakagawa, Mayumi
Funding for this research was provided by:
National Cancer Institute (R01CA143130)
National Center for Advancing Translational Sciences (UL1TR000039)
National Institute of General Medical Sciences (P20GM103429, P30GM103450, P20GM103625)
Article History
Received: 6 November 2015
Accepted: 27 February 2016
First Online: 15 March 2016
Compliance with ethical standards
:
: Mayumi Nakagawa is one of the inventors named in patents and patent applications describing PepCan. Other authors do not have any conflict of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board, the Food and Drug Administration, and with the 1964 Helsinki Declaration including its later amendments.
: Informed consent was obtained from all individual participants included in the study.